BIOTRONIK

284 articles about BIOTRONIK

• BIOTRONIK Selectra Lead Introducer System Gets Strong Reviews in First Cases

  9/27/2011

• BIOTRONIK Announces Completion of Enrollment in the BIOLUX P-I Clinical Study Investigating Drug-eluting Balloon Therapy for Peripheral Artery Disease

  9/20/2011

• BIOTRONIK Announces European Market Approval of Selectra: Advanced New Telescopic CRT Lead Delivery System

  9/2/2011

• PREVENT Study Indicates Potential for Reduced Risk of Adverse Clinical Outcomes with Enhanced BIOTRONIK Pacemaker Algorithm

  9/1/2011

• ECOST Trial Demonstrates for the First Time That Daily Remote Monitoring with BIOTRONIK Home Monitoring(R) Reduces Inappropriate Shocks and Improves Battery Longevity for ICD Patients

  8/30/2011

• Publication of BIOTRONIK Home-CARE Clinical Study Results Confirms Potential New Approach for Earlier Detection of Cardiovascular Events

  8/26/2011

• BIOTRONIK Announces Compelling Program of Clinically and Scientifically Significant Presentations at European Society of Cardiology Congress 2011

  8/25/2011

• BIOTRONIK Vascular Enters U.S. with First Peripheral Stent Implant in BIOFLEX-I IDE Clinical Trial

  7/22/2011

• BIOTRONIK Announces First Patients Treated in BIOFLOW-II Clinical Study Comparing ORSIRO Hybrid Drug-Eluting Stent to Abbott's XIENCE PRIME(TM)

  7/13/2011

• BIOTRONIK Announces Completion of Enrollment in the 4EVER Clinical Study Including Long Lesions in Peripheral Vascular Disease

  6/28/2011

• BIOTRONIK Launches Lumax 540 VR-T DX, The World’s Only Single-Chamber ICD With Complete Atrial Diagnostics

  6/24/2011

• BIOTRONIK Announces Positive 6-Month Results for DREAMS, the Pioneering Drug-Eluting Absorbable Metal Scaffold

  5/19/2011

• Industry’s First Hybrid Drug-Eluting Stent from BIOTRONIK Demonstrates Safety and Efficacy in First-in-Man Clinical Experience

  5/18/2011

• BIOTRONIK Announces Positive 6-Month Results for DREAMS, the Pioneering Drug-Eluting Absorbable Metal Scaffold

  5/18/2011

• BIOTRONIK Announces US Market Release for Renamic: Next Generation Programmer for Implantable Cardiac Devices

  4/28/2011

• BIOTRONIK Receives FDA Approval for Expansion of the Premium Evia Pacemaker Portfolio

  4/27/2011

• BIOTRONIK Announces US Market Release of Selectra: Advanced New CRT Lead Delivery System

  4/27/2011

• Novation Announces the Addition of Cardiac Rhythm Management Product Supplier BIOTRONIK

  4/22/2011

• BIOTRONIK Implants Linked with Possible Physician Kickbacks

  4/7/2011

• BIOTRONIK Cardiac Device Donation Helps 75 Impoverished Heart Patients in Trinidad and Tobago

  4/7/2011